Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENDURA-1: Depemokimab in COPD with Type 2 inflammation
jRCT2031250253Recruiting
- Sponsor
- GSK
- Start
- Aug 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Depemokimab arm with Placebo arm (2 arms). Primary endpoint: Annualized Rate of Moderate/Severe Exacerbations. Started Aug 2025; status: recruiting.
02
Drugs
depemokimab
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on jRCT2031250253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250253.